Zobrazeno 1 - 10
of 35
pro vyhledávání: '"C. Philip Steuber"'
Autor:
Jennifer Shroff Pendley, Donna S. Landthrip, Lynnda M. Dahlquist, C. Philip Steuber, Cheri L. Jones
Publikováno v:
Health Psychology. 21:94-99
This study evaluated a distraction intervention designed to reduce the distress of preschool children undergoing repeated chemotherapy injections. Twenty-nine children aged 2-5 years were randomly assigned either to distraction by a developmentally a
Autor:
Cheri L. Jones, Lynnda M. Dahlquist, Donna S. Landthrip, C. Philip Steuber, Thomas G. Power, Jennifer Shroff Pendley
Publikováno v:
Children's Health Care. 30:151-167
In this study, we examined the ways in which adults issued commands to children (adult command structure) and children's distress during invasive cancer procedures. Forty-five children with cancer, ages 5-15 years, were videotaped during an intramusc
Autor:
Ruprecht Nitschke, C. Philip Steuber, Donald H. Mahoney, Bruce M. Camitta, Jonathan J. Shuster, Stephen Lauer
Publikováno v:
Journal of Clinical Oncology. 18:1285-1294
PURPOSE: To determine whether early intensification with 12 courses of intravenous (IV) methotrexate (MTX) and IV mercaptopurine (MP) is superior to 12 courses of IV MTX alone for prevention of relapse in children with lower-risk B-lineage acute lymp
Autor:
Donald H. Mahoney, Michael L. Graham, Stephen J. Lauer, Jeanette Pullen, Brigid G. Leventhal, Curt I. Civin, Stuart E. Adair, Barton A. Kamen, James T. Casper, C. Philip Steuber, Jonathan J. Shuster, Geri Kiefer, Bruce M. Camitta
Publikováno v:
Cancer. 71:2854-2861
Background To prevent drug resistance, the authors designed a protocol that featured early intensive rotating drug pairs as part of the therapy for acute lymphoblastic leukemia (ALL). Methods After prednisone, vincristine, asparaginase, and daunorubi
Autor:
C. Philip Steuber, Michael J. Borowitz, Andrew J. Carroll, Michael J. Schell, William M. Crist, Michael P. Link, David R. Head, Ching-Hon Pui, Jonathan J. Shuster, Susana C. Raimondi, Vita J. Land, Frederick G. Behm
Publikováno v:
Blood. 79:2384-2391
Cytogenetic analysis of leukemic cells from 2,805 children with newly diagnosed acute lymphoblastic leukemia (ALL) identified 83 cases (3%) that had a stemline with at least one isochromosome. The i(9q) was present in 28 (1%), the i(17q) in 23 (0.8%)
Autor:
Kiyoshi Takatsuki, Akihiro Shimosaka, Jorge A. Ortega, Vita J. Land, Teresa J. Vietti, Hiroyuki Tsuchiya, Susan R. Wiersma, Michael J. Schell, Gaston K. Rivera, William M. Crist, Masahiko Watanabe, Kenneth I. Weinberg, Ichiro Matsuda, Eugene Sobel, Jonathan J. Shuster, David R. Head, Susana C. Raimondi, Michael J. Borowitz, Ching-Hon Pui, Norio Asou, Frederick G. Behm, C. Philip Steuber, D. Jeanette Pullen
Publikováno v:
New England Journal of Medicine. 325:1378-1382
Autor:
Vita J. Land, Frederick G. Behm, Lawrence S. Frankel, David R. Head, C. Philip Steuber, Michael J. Borowitz, Jonathan J. Shuster, Andrew J. Carroll, William M. Crist, D. Jeanette Pullen, Susana C. Raimondi, Ching-Hon Pui
Publikováno v:
Blood. 77:440-447
The t(4;11)(q21;q23) chromosomal abnormality was identified in 40 (2%) of 1,986 children with newly diagnosed acute lymphoblastic leukemia (ALL). This translocation was associated with female sex (63%), age less than 1 year (60%), hyperleukocytosis (
Autor:
Wayne L. Furman, Clinton F. Stewart, Mark Kirstein, James L. Kepner, Mark L. Bernstein, Faith Kung, Teresa J. Vietti, C. Philip Steuber, David Lee Becton, Sylvain Baruchel, Charles Pratt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(6)
PURPOSE: To determine dose-limiting toxicity (DLT) and maximum-tolerated dose (MTD) of a protracted, intermittent schedule of daily 30-minute infusions of topotecan (TPT) for up to 12 consecutive days, every 3 weeks, in children with refractory leuke
Autor:
C. Philip Steuber, W. Paul Bowman, Mark L. Bernstein, Susan Devine, Stuart Toledano, Thomas C. Abshire, George R. Buchanan, Bradley H Pollock
Publikováno v:
Journal of pediatric hematology/oncology. 19(1)
Purpose: This study was designed to determine the toxicity of and response to idarubicin and cytosine arabinoside in children and adolescents with acute lymphoblastic leukemia (ALL) who had refractory or recurrent bone marrow disease. Patients and Me
Autor:
La Mei, ZoAnn E. Dreyer, C. Philip Steuber, Camitta Bruce, Winick Naomi, Hilden M. Joanne, Hunger Stephen, Carroll L. William, Patricia Dinndorf
Publikováno v:
Blood. 110:852-852
Infants with Acute Lymphoid Leukemia (ALL) have a poor event free survival (EFS) characterized by early relapse typically occurring less than 6–9 months after diagnosis. More than 70% of these infants have evidence of the MLL gene rearrangement in